CAPTRUST Financial Advisors’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
DGI
C
FCM
CAPTRUST Financial Advisors's TVRD Position: Q4 2023 in Review
CAPTRUST Financial Advisors sold out of Tvardi Therapeutics (TVRD) in Q4 2023, closing a stake of 442 shares — an estimated $26.7K sold.
CAPTRUST Financial Advisors first reported a position in TVRD in Q1 2018 and held it in 19 quarters. The position peaked at $172K in Q4 2022. 109 funds tracked by Wall St. Rank hold TVRD as of Q4 2023.
- CAPTRUST Financial Advisors reported no remaining Tvardi Therapeutics position as of Q4 2023 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 442 Tvardi Therapeutics shares in Q4 2023, an estimated $26.7K.
- CAPTRUST Financial Advisors first reported a position in Tvardi Therapeutics in Q1 2018 and held it in 19 quarters.
- CAPTRUST Financial Advisors's Tvardi Therapeutics position peaked at $172K in Q4 2022.
- 109 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2023.
Based on CAPTRUST Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.